These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38976858)

  • 1. Harm Reduction in Psychiatric Settings.
    Kverno K
    J Psychosoc Nurs Ment Health Serv; 2024 Jul; 62(7):7-10. PubMed ID: 38976858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Treatment of Tobacco Use Disorder.
    Davis A
    J Psychosoc Nurs Ment Health Serv; 2023 Nov; 61(11):6-9. PubMed ID: 37909890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction.
    Fraimow-Wong L; Martín M; Thomas L; Giuliano R; Nguyen OK; Knight K; Suen LW
    JAMA Netw Open; 2024 Feb; 7(2):e240229. PubMed ID: 38386317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?
    Prochaska JJ
    Drug Alcohol Depend; 2010 Aug; 110(3):177-82. PubMed ID: 20378281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-month prevalence of psychiatric disorders and treatment-seeking among Asian Americans/Pacific Islanders in the United States: results from the National Epidemiological Survey on Alcohol and Related Conditions.
    Xu Y; Okuda M; Hser YI; Hasin D; Liu SM; Grant BF; Blanco C
    J Psychiatr Res; 2011 Jul; 45(7):910-8. PubMed ID: 21238989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder.
    Glass JE; Williams EC; Bucholz KK
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1697-705. PubMed ID: 24848495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Many Recovery Attempts Does it Take to Successfully Resolve an Alcohol or Drug Problem? Estimates and Correlates From a National Study of Recovering U.S. Adults.
    Kelly JF; Greene MC; Bergman BG; White WL; Hoeppner BB
    Alcohol Clin Exp Res; 2019 Jul; 43(7):1533-1544. PubMed ID: 31090945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatrically impaired medical practitioners: better care to reduce harm and life impact, with special reference to impaired psychiatrists.
    Rosen A; Wilson A; Randal P; Pethebridge A; Codyre D; Barton D; Norrie P; McGeorge P; Rose L
    Australas Psychiatry; 2009 Feb; 17(1):11-8. PubMed ID: 19137466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.
    Collins SE; Duncan MH; Saxon AJ; Taylor EM; Mayberry N; Merrill JO; Hoffmann GE; Clifasefi SL; Ries RK
    Lancet Psychiatry; 2021 Apr; 8(4):287-300. PubMed ID: 33713622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability and predictors of treatment-seeking for substance use disorders in the U.S.
    Blanco C; Iza M; Rodríguez-Fernández JM; Baca-García E; Wang S; Olfson M
    Drug Alcohol Depend; 2015 Apr; 149():136-44. PubMed ID: 25725934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm Reduction: Not Dirty Words Any More.
    Ramprashad A; Burnett GM; Welsh C
    Psychiatr Clin North Am; 2022 Sep; 45(3):529-546. PubMed ID: 36055737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-free treatment selection for chemical abusers: a diagnostic-based model.
    Sandberg C; Greenberg WM; Birkmann JC
    Am J Orthopsychiatry; 1991 Jul; 61(3):358-71. PubMed ID: 1951643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agency and addiction in a harm reduction paradigm: French nurses' perspectives.
    Gray MT
    Arch Psychiatr Nurs; 2014 Feb; 28(1):35-42. PubMed ID: 24506985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment.
    Fox AD; Chamberlain A; Frost T; Cunningham CO
    Subst Abus; 2015; 36(2):155-60. PubMed ID: 25837290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm Reduction as "Continuum Care" in Alcohol Abuse Disorder.
    Maremmani I; Cibin M; Pani PP; Rossi A; Turchetti G
    Int J Environ Res Public Health; 2015 Nov; 12(11):14828-41. PubMed ID: 26610535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumer and practitioner perceptions of the harm reduction approach in a community mental health setting.
    Mancini MA; Wyrick-Waugh W
    Community Ment Health J; 2013 Feb; 49(1):14-24. PubMed ID: 22009266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalized stigma among patients with substance use disorders at a tertiary care center in India.
    Sarkar S; Balhara YPS; Kumar S; Saini V; Kamran A; Patil V; Singh S; Gyawali S
    J Ethn Subst Abuse; 2019; 18(3):345-358. PubMed ID: 28898165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IOM Report on Psychosocial Interventions for Mental and Substance Use Disorders: Opportunities for Psychiatric-Mental Health Nurses.
    Adams S
    J Am Psychiatr Nurses Assoc; 2015; 21(5):343-7. PubMed ID: 26511436
    [No Abstract]   [Full Text] [Related]  

  • 20. Kratom as a potential substance use disorder harm reduction agent.
    Green M; Vadiei N; Veltri CA; Grundmann O; Evoy KE
    Front Public Health; 2024; 12():1416689. PubMed ID: 38873312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.